{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T15:23:58Z","timestamp":1707578638168},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,4,3]],"date-time":"2012-04-03T00:00:00Z","timestamp":1333411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12149-012-0595-2","type":"journal-article","created":{"date-parts":[[2012,4,2]],"date-time":"2012-04-02T04:16:14Z","timestamp":1333340174000},"page":"426-435","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of sequential FDG-PET\/CT for monitoring bone metastasis of breast cancer during therapy: correlation between morphological and metabolic changes with tumor markers"],"prefix":"10.1007","volume":"26","author":[{"given":"Takashi","family":"Katayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youichi","family":"Machida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Toriihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,3]]},"reference":[{"key":"595_CR1","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1200\/JCO.2005.05.116","volume":"23","author":"N Kohno","year":"2005","unstructured":"Kohno N, Aogi K, Minami H, Nakamura S, Asaga T, Iino Y, et al. Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial. J Clin Oncol. 2005;23:3314\u201321.","journal-title":"J Clin Oncol"},{"key":"595_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00003086-200203000-00029","volume":"396","author":"HR D\u00fcrr","year":"2002","unstructured":"D\u00fcrr HR, M\u00fcller PE, Lenz T, Baur A, Jansson V, Refior HJ. Surgical treatment of bone metastases in patients with breast cancer. Clin Orthop Relat Res. 2002;396:191\u20136.","journal-title":"Clin Orthop Relat Res"},{"key":"595_CR3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-Y","volume":"50","author":"D Tong","year":"1982","unstructured":"Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group. Cancer. 1982;50:893\u20139.","journal-title":"Cancer"},{"key":"595_CR4","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/1097-0142(19850401)55:7<1468::AID-CNCR2820550708>3.0.CO;2-M","volume":"55","author":"PH Blitzer","year":"1985","unstructured":"Blitzer PH. Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer. 1985;55:1468\u201372.","journal-title":"Cancer"},{"key":"595_CR5","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","volume":"21","author":"BE Hillner","year":"2003","unstructured":"Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol. 2003;21:4042\u201357.","journal-title":"J Clin Oncol"},{"key":"595_CR6","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1200\/JCO.2007.11.2854","volume":"25","author":"Y Du","year":"2007","unstructured":"Du Y, Cullum I, Illidge TM, Ell PJ. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography\/ computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. J Clin Oncol. 2007;25:3440\u20137.","journal-title":"J Clin Oncol"},{"key":"595_CR7","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2004.08.181","volume":"22","author":"T Hamaoka","year":"2004","unstructured":"Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22:2942\u201353.","journal-title":"J Clin Oncol"},{"key":"595_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1148\/radiol.2471070567","volume":"247","author":"U Tateishi","year":"2008","unstructured":"Tateishi U, Gamez C, Dawood S, Yeung HW, Cristofanilli M, Macapinlac HA. Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET\/CT. Radiology. 2008;247:189\u201396.","journal-title":"Radiology"},{"key":"595_CR9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0009-9260(87)80207-6","volume":"38","author":"EA Bellamy","year":"1987","unstructured":"Bellamy EA, Nicholas D, Ward M, Coombes RC, Powles TJ, Husband JE. Comparison of computed tomography and conventional radiology in the assessment of treatment response of lytic bony metastases in patients with carcinoma of the breast. Clin Radiol. 1987;38:351\u20135.","journal-title":"Clin Radiol"},{"key":"595_CR10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"595_CR11","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50:122S\u201350S.","journal-title":"J Nucl Med"},{"key":"595_CR12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra050276","volume":"354","author":"ME Juweid","year":"2006","unstructured":"Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;354:496\u2013507.","journal-title":"N Engl J Med"},{"key":"595_CR13","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","volume":"35","author":"H Young","year":"1999","unstructured":"Young H, Baum R, Cremerius U, HerHolz K, Hoekstra O, Lammertsma AA, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer. 1999;35:1773\u201382.","journal-title":"Eur J Cancer"},{"key":"595_CR14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1440-1681.2002.03686.x","volume":"29","author":"J Ludbrook","year":"2002","unstructured":"Ludbrook J. Statistical techniques for comparing measurers and methods of measurement: a critical review. Clin Exp Pharmacol Physiol. 2002;29:527\u201336.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"595_CR15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1148\/radiol.2212010280","volume":"221","author":"M G\u00f6nen","year":"2001","unstructured":"G\u00f6nen M, Panageas KS, Larson SM. Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient. Radiology. 2001;221:763\u20137.","journal-title":"Radiology"},{"key":"595_CR16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10585-009-9247-x","volume":"26","author":"E Amir","year":"2009","unstructured":"Amir E, Whyne C, Freedman OC, Fralick M, Kumar R, Hardisty M, et al. Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastases. Clin Exp Metastasis. 2009;26:479\u201384.","journal-title":"Clin Exp Metastasis"},{"key":"595_CR17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0360-3016(03)00525-X","volume":"57","author":"V Kouloulias","year":"2003","unstructured":"Kouloulias V, Matsopoulos G, Kouvaris J, Dardoufas C, Bottomley A, Varela M, et al. Radiotherapy in conjunction with intravenous infusion of 180\u00a0mg of disodium pamidronate in management of osteolytic metastases from breast cancer: clinical evaluation, biochemical markers, quality of life, and monitoring of recalcification using assessments of gray-level histogram in plain radiographs. Int J Radiat Oncol Biol Phys. 2003;57:143\u201357.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"595_CR18","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1388::AID-CNCR4>3.0.CO;2-H","volume":"78","author":"T Yamaguchi","year":"1996","unstructured":"Yamaguchi T, Tamai K, Yamato M, Honma K, Ueda Y, Saotome K. Intertrabecular pattern of tumors metastatic to bone. Cancer. 1996;78:1388\u201394.","journal-title":"Cancer"},{"key":"595_CR19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2001-15676","volume":"5","author":"T Yamaguchi","year":"2001","unstructured":"Yamaguchi T. Intertrabecular vertebral metastases: metastases only detectable on MR imaging. Semin Musculoskelet Radiol. 2001;5:171\u20135.","journal-title":"Semin Musculoskelet Radiol."},{"key":"595_CR20","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1200\/JCO.1998.16.10.3375","volume":"16","author":"GJ Cook","year":"1998","unstructured":"Cook GJ, Houston S, Rubens R, Maisey MN, Fogelman I. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol. 1998;16:3375\u20139.","journal-title":"J Clin Oncol"},{"key":"595_CR21","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2214\/ajr.184.4.01841266","volume":"184","author":"T Uematsu","year":"2005","unstructured":"Uematsu T, Yuen S, Yukisawa S, Aramaki T, Morimoto N, Endo M. Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer. Am J Roentgenol. 2005;184:1266\u201373.","journal-title":"Am J Roentgenol"},{"key":"595_CR22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00259-005-1842-8","volume":"32","author":"T Nakai","year":"2005","unstructured":"Nakai T, Okuyama C, Kubota T, Yamada K, Ushijima Y, Taniike K, et al. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imaging. 2005;32:1253\u20138.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"595_CR23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF02985050","volume":"19","author":"K Abe","year":"2005","unstructured":"Abe K, Sasaki M, Kuwabara Y, Koga H, Baba S, Hayashi K, et al. Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer. Ann Nucl Med. 2005;19:573\u20139.","journal-title":"Ann Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-012-0595-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-012-0595-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-012-0595-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T04:41:21Z","timestamp":1559450481000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-012-0595-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,3]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["595"],"URL":"https:\/\/doi.org\/10.1007\/s12149-012-0595-2","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,3]]}}}